Impax Asset Management Group PLC Integra Lifesciences Holdings Corp Transaction History

Impax Asset Management Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Nov 08, 2024	BUY	$23.14 - $34.72 $511,509 - $767,485	22,105 New	22,105 $644,000
Q2 2024 Aug 05, 2024	BUY	$23.14 - $34.72 $511,509 - $767,485	22,105 New	22,105 $644,000
Q3 2020 Nov 12, 2020	SELL	$43.33 - $51.72 $5.76 Million - $6.88 Million	-133,015 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$41.42 - $55.57 $746,181 - $1 Million	18,015 Added 15.67%	133,015 $6.25 Million
Q1 2020 May 15, 2020	BUY	$36.67 - $61.04 $916,750 - $1.53 Million	25,000 Added 27.78%	115,000 $5.14 Million
Q4 2019 Feb 13, 2020	BUY	$55.73 - $62.49 $1.95 Million - $2.19 Million	35,000 Added 63.64%	90,000 $5.25 Million
Q3 2019 Nov 14, 2019	BUY	$53.29 - $64.59 $2.93 Million - $3.55 Million	55,000 New	55,000 $3.3 Million

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.